Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.88B 575M 500M 465M 427M 807M 54.88B 819M 5.48B 2.15B 27.32B 2.16B 2.11B 91.62B P/E 2026 *
8.54x
P/E 2027 * 7.58x
Enterprise Value 3.88B 575M 500M 465M 427M 807M 54.88B 819M 5.48B 2.15B 27.32B 2.16B 2.11B 91.62B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.51x
Free-Float
45.7%
Yield 2026 *
5.28%
Yield 2027 * 5.94%
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
13/01 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
31/12 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 week+1.10%
Current month+9.58%
1 month+9.58%
3 months-8.96%
6 months-17.94%
Current year-19.38%
1 week 0.36
Extreme 0.364
0.38
1 month 0.33
Extreme 0.332
0.38
3 years 0.32
Extreme 0.324
0.81
5 years 0.32
Extreme 0.324
1
10 years 0.32
Extreme 0.324
1.81
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%+1.10%-34.05%-53.96% 575M
+0.21%+3.65%-5.74%-1.80% 13.96B
+0.15%+5.03%-26.87%-48.42% 5.34B
-1.12%+7.35%+5.85%+11.70% 5.16B
+1.56%+2.99%+4.07%-32.30% 4.18B
-0.03%+4.59%+2.96%-2.25% 3.79B
-0.33%+0.68%-0.04%+1.86% 3.66B
+1.51%+2.28%-1.65%+14.25% 3.57B
+0.90%+2.07%-13.36%-22.67% 2.46B
-2.04%+4.97%+0.88%+51.02% 1.92B
Average +0.09%+2.19%-6.80%-8.26% 4.89B
Weighted average by Cap. +0.16%+2.68%-4.98%-6.69%

Financials

2026 *2027 *
Net sales 6.98B 1.03B 899M 836M 768M 1.45B 98.67B 1.47B 9.86B 3.87B 49.12B 3.88B 3.8B 165B 7.56B 1.12B 973M 906M 832M 1.57B 107B 1.6B 10.68B 4.19B 53.21B 4.2B 4.11B 178B
Net income 454M 67.29M 58.49M 54.44M 49.99M 94.39M 6.42B 95.85M 642M 252M 3.2B 253M 247M 10.72B 514M 76.02M 66.08M 61.51M 56.47M 107M 7.26B 108M 725M 285M 3.61B 286M 279M 12.11B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
-
Date Price Change
31/07/26 EUR 0.3660 -1.08%
30/07/26 EUR 0.3700 +1.65%
29/07/26 EUR 0.3640 -1.62%
28/07/26 EUR 0.3700 -.--%
27/07/26 EUR 0.3700 +2.21%
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.032CNY
Average target price
4.601CNY
Spread / Average Target
+51.74%

Annual profits - Rate of surprise